 | |
| Clinical data | |
|---|---|
| Other names | Dioxifedrin; α-Methylepinephrine; α-Methyladrenaline; 3,4-Dihydroxyephedrine; Dioxyephedrine; Sor-N 49; Diphedran; LD-1205; 3,4,β-Trihydroxy-α,N-dimethylphenethylamine; 3,4,β-Trihydroxy-N-methylamphetamine |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.030.639 |
| Chemical and physical data | |
| Formula | C10H15NO3 |
| Molar mass | 197.234 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Dioxifedrine (INNTooltip International Nonproprietary Name), ordioxifedrin, also known asα-methylepinephrine or as3,4-dihydroxyephedrine, is asympathomimeticmedication that was never marketed.[1][2][3][4] It is described as aβ-adrenergic receptor agonist andbronchodilator.[1][5][6] The drug is asubstituted phenethylamine andamphetamine and is thecatecholamine (3,4-dihydroxylated)derivative ofephedrine and the amphetamine (α-methylated)analogue ofepinephrine (adrenaline).[1][2] Analogues of dioxifedrine includedioxethedrin (α-methyl-N-ethylnorepinephrine),corbadrine (levonordefrin; α-methylnorepinephrine), andα-methyldopamine.[1]
 | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it. |